Tuberculous dactylitis

Last updated
Tuberculous dactylitis
Specialty Infectious disease

Tuberculous dactylitis, also known as spina ventosa [1] , is a skeletal manifestation of tuberculosis, one of the commonest forms of bacterial osteitis. It affects children more often than adults. [2] The first radiological description of the condition is credited to Feilchenfeld in 1896; however, the first histological description was given by Rankin in 1886. [3] The Swedish botanist and physician Carl von Linne was the first to mention the condition by the name spina ventosa (lit. inflated bone). [4]

Contents

Multiple bones are involved in children and usually only a single bone is involved in adults suffering from tuberculous dactylitis. [2] Tuberculous dactylitis affects the short tubular bones of the hands and feet in children. It often follows a mild course without fever and acute inflammatory signs as opposed to acute osteomyelitis. There may be a gap of a few months to 2 to 3 years from the time of initial infection to the point of diagnosis. [5] [6] [7]

Nearly 85% of patients with spina ventosa are below 6 years of age. The bones of hands are more commonly involved than those of the feet. The proximal phalanx of the index and middle fingers are the commonest sites of involvement. Up to nearly 7% of children with pulmonary tuberculosis may develop this condition. [8] Spread to the skeletal system is believed to occur via blood and lymphatics. [9]

Signs and symptoms

Pathogenesis

In the pediatric age group, the marrow in the phalangeal bones are still active, a conducive place for the tuberculous bacilli to multiply. Slowly, the whole marrow space gets involved and this underlying granulomatous disease leads to expansion of the overlying soft cortex. Finally there is a fusiform dilation of the bone, with thinned out cortex and destruction of the marrow space leading to a balloon like shape; this cystic expansion of the bone is termed as spina ventosa. [10]

Diagnosis

The diagnosis of the condition is made on the basis of histological and bacteriological studies. Tuberculosis dactylitis may be confused with conditions like osteomyelitis, gout, sarcoidosis and tumors. [11] [12]

Treatment

Spina ventosa is mainly treated conservatively. Most patients respond to anti tuberculosis treatment. The regimen consists of initial two months' intensive therapy with isoniazid, rifampicin, ethambutol and pyrazinamide followed by a six to twelve month course of isoniazid and rifampicin [13] [14] . Almost all the patients respond to medical therapy. Surgery is limited in curetting the bone cavities to promote early healing in cystic tuberculosis.

Related Research Articles

<span class="mw-page-title-main">Mycobacterial cervical lymphadenitis</span> Human medical condition

The disease mycobacterial cervical lymphadenitis, also known as scrofula and historically as king's evil, involves a lymphadenitis of the cervical lymph nodes associated with tuberculosis as well as nontuberculous (atypical) mycobacteria.

<span class="mw-page-title-main">Osteopetrosis</span> Rare disease of the bones

Osteopetrosis, literally "stone bone", also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften. Osteopetrosis can cause bones to dissolve and break.

<span class="mw-page-title-main">Osteomyelitis</span> Infection of the bones

Osteomyelitis (OM) is an infection of bone. Symptoms may include pain in a specific bone with overlying redness, fever, and weakness. The long bones of the arms and legs are most commonly involved in children e.g. the femur and humerus, while the feet, spine, and hips are most commonly involved in adults.

<span class="mw-page-title-main">Isoniazid</span> Antibiotic for treatment of tuberculosis

Isoniazid, also known as isonicotinic acid hydrazide (INH), is an antibiotic used for the treatment of tuberculosis. For active tuberculosis, it is often used together with rifampicin, pyrazinamide, and either streptomycin or ethambutol. For latent tuberculosis, it is often used alone. It may also be used for atypical types of mycobacteria, such as M. avium, M. kansasii, and M. xenopi. It is usually taken by mouth, but may be used by injection into muscle.

<span class="mw-page-title-main">Rifampicin</span> Antibiotic medication

Rifampicin, also known as rifampin, is an ansamycin antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), Mycobacterium avium complex, leprosy, and Legionnaires' disease. It is almost always used together with other antibiotics with two notable exceptions: when given as a "preferred treatment that is strongly recommended" for latent TB infection; and when used as post-exposure prophylaxis to prevent Haemophilus influenzae type b and meningococcal disease in people who have been exposed to those bacteria. Before treating a person for a long period of time, measurements of liver enzymes and blood counts are recommended. Rifampicin may be given either by mouth or intravenously.

<span class="mw-page-title-main">Tuberculosis management</span>

Tuberculosis management describes the techniques and procedures utilized for treating tuberculosis (TB).

<span class="mw-page-title-main">Miliary tuberculosis</span> Medical condition

Miliary tuberculosis is a form of tuberculosis that is characterized by a wide dissemination into the human body and by the tiny size of the lesions (1–5 mm). Its name comes from a distinctive pattern seen on a chest radiograph of many tiny spots distributed throughout the lung fields with the appearance similar to millet seeds—thus the term "miliary" tuberculosis. Miliary TB may infect any number of organs, including the lungs, liver, and spleen. Miliary tuberculosis is present in about 2% of all reported cases of tuberculosis and accounts for up to 20% of all extra-pulmonary tuberculosis cases.

<i>Brucella</i> Genus of bacteria

Brucella is a genus of Gram-negative bacteria, named after David Bruce (1855–1931). They are small, nonencapsulated, nonmotile, facultatively intracellular coccobacilli.

<span class="mw-page-title-main">Pyrazinamide</span> Medication

Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth.

<span class="mw-page-title-main">4-Aminosalicylic acid</span> Anti-tuberculosis and anti-inflammatory drug

4-Aminosalicylic acid, also known as para-aminosalicylic acid (PAS) and sold under the brand name Paser among others, is an antibiotic primarily used to treat tuberculosis. Specifically it is used to treat active drug resistant tuberculosis together with other antituberculosis medications. It has also been used as a second line agent to sulfasalazine in people with inflammatory bowel disease such as ulcerative colitis and Crohn's disease. It is typically taken by mouth.

<span class="mw-page-title-main">Nonunion</span> Failure of a bone to heal after breakage

Nonunion is permanent failure of healing following a broken bone unless intervention is performed. A fracture with nonunion generally forms a structural resemblance to a fibrous joint, and is therefore often called a "false joint" or pseudoarthrosis. The diagnosis is generally made when there is no healing between two sets of medical imaging, such as X-ray or CT scan. This is generally after 6–8 months.

<span class="mw-page-title-main">Plasmacytoma</span> Growth of a plasma cell tumour within soft tissue or the axial skeleton

Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within the axial skeleton.

<span class="mw-page-title-main">Lupus vulgaris</span> Human disease

Lupus vulgaris are painful cutaneous tuberculosis skin lesions with nodular appearance, most often on the face around the nose, eyelids, lips, cheeks, ears and neck. It is the most common Mycobacterium tuberculosis skin infection. The lesions may ultimately develop into disfiguring skin ulcers if left untreated.

<i>Mycobacterium avium-intracellulare</i> infection Medical condition

Mycobacterium avium-intracellulare infection (MAI) is an atypical mycobacterial infection, i.e. one with nontuberculous mycobacteria or NTM, caused by Mycobacterium avium complex (MAC), which is made of two Mycobacterium species, M. avium and M. intracellulare. This infection causes respiratory illness in birds, pigs, and humans, especially in immunocompromised people. In the later stages of AIDS, it can be very severe. It usually first presents as a persistent cough. It is typically treated with a series of three antibiotics for a period of at least six months.

<span class="mw-page-title-main">Tuberculoma</span> Tumor-like mass resulting from the enlargement of a tuberculous lesion

A tuberculoma is a clinical manifestation of tuberculosis which conglomerates tubercles into a firm lump, and so can mimic cancer tumors of many types in medical imaging studies. They often arise within individuals in whom a primary tuberculosis infection is not well controlled. When tuberculomas arise intracranially, they represent a manifestation of CNS tuberculosis. Since these are evolutions of primary complex, the tuberculomas may contain caseum or calcifications.

<span class="mw-page-title-main">Tuberculous meningitis</span> Medical condition

Tuberculous meningitis, also known as TB meningitis or tubercular meningitis, is a specific type of bacterial meningitis caused by the Mycobacterium tuberculosis infection of the meninges—the system of membranes which envelop the central nervous system.

<span class="mw-page-title-main">Ethionamide</span> Chemical compound

Ethionamide is an antibiotic used to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. It is no longer recommended for leprosy. It is taken by mouth.

<span class="mw-page-title-main">Multidrug-resistant tuberculosis</span> Medical condition

Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampin. Some forms of TB are also resistant to second-line medications, and are called extensively drug-resistant TB (XDR-TB).

Vertebral osteomyelitis is a type of osteomyelitis that affects the vertebrae. It is a rare bone infection concentrated in the vertebral column. Cases of vertebral osteomyelitis are so rare that they constitute only 2%-4% of all bone infections. The infection can be classified as acute or chronic depending on the severity of the onset of the case, where acute patients often experience better outcomes than those living with the chronic symptoms that are characteristic of the disease. Although vertebral osteomyelitis is found in patients across a wide range of ages, the infection is commonly reported in young children and older adults. Vertebral osteomyelitis often attacks two vertebrae and the corresponding intervertebral disk, causing narrowing of the disc space between the vertebrae. The prognosis for the disease is dependent on where the infection is concentrated in the spine, the time between initial onset and treatment, and what approach is used to treat the disease.

<span class="mw-page-title-main">Extrapulmonary tuberculosis</span> Medical condition

Extrapulmonary tuberculosis is tuberculosis (TB) within a location in the body other than the lungs. It accounts for an increasing fraction of active cases, from 20 to 40% according to published reports, and causes other kinds of TB. These are collectively denoted as "extrapulmonary tuberculosis". Extrapulmonary TB occurs more commonly in immunosuppressed persons and young children. In those with HIV, this occurs in more than 50% of cases. Notable extrapulmonary infection sites include the pleura, the central nervous system, the lymphatic system, the genitourinary system, and the bones and joints, among others.

References

  1. Cremin, B. J.; Jamieson, D. H. (1995). "Imaging of Skeletal Tuberculosis". Childhood Tuberculosis: Modern Imaging and Clinical Concepts. London: Springer-Verla. p. 99. doi:10.1007/978-1-4471-3011-6_6. ISBN   978-1-4471-3013-0. Reviewed in Cant, A. J. (1996). "Childhood Tuberculosis. Modern Imaging and Clinical Concepts". Archives of Disease in Childhood. 75 (4): 359. doi:10.1136/adc.75.4.359-a. PMC   1511729 .
  2. 1 2 Vuyst, Dimitri De; Vanhoenacker, Filip; Gielen, Jan; Bernaerts, Anja; Schepper, Arthur M. De (2003). "Imaging features of musculoskeletal tuberculosis". European Radiology. 13 (8): 1809–19. doi:10.1007/s00330-002-1609-6. PMID   12942283. S2CID   13465651.
  3. Pearlman, H. S.; Warren, R. F. (1961). "Tuberculous dactylitis". American Journal of Surgery. 101 (6): 769–71. doi:10.1016/0002-9610(61)90724-3. PMID   13733764.
  4. Linnaeus, Carl (1978). Västgöta resa år 1746. Stockholm: Wahlström & widstrand. p. 131. ISBN   91-46-13190-6.
  5. Subasi, M; Bukte, Y; Kapukaya, A; Gurkan, F (2004). "Tuberculosis of the metacarpals and phalanges of the hand". Annals of Plastic Surgery. 53 (5): 469–72. doi:10.1097/01.sap.0000130708.80606.6a. PMID   15502464. S2CID   35203922.
  6. Coombs, R; Fitzgerald, FH (1989). Infection in the orthopaedic patient. Great Britain: Butterworth & Co Ltd. pp. 297–8. ISBN   978-0-407-01316-2.
  7. Al-Qattan, MM; Bowen, V; Manteo, RT (1994). "Tuberculosis of the hand". Journal of Hand Surgery (Edinburgh, Scotland). 19 (2): 234–7. doi:10.1016/0266-7681(94)90175-9. PMID   8014559. S2CID   39092144.
  8. Salimpour, R.; Salimpour, P. (1997). "Picture of the month. Tuberculous dactylitis". Archives of Pediatrics & Adolescent Medicine. 151 (8): 851–2. doi:10.1001/archpedi.1997.02170450101018. PMID   9265892.
  9. Zoga, A; Lee, V. W. (1999). "Paediatric case of the day. Tuberculosis dactylitis and primary pulmonary tuberculosis". American Journal of Roentgenology. 173 (3): 813, 815–7. doi: 10.2214/ajr.173.3.10470936 . PMID   10470936.
  10. Bhaskar; Tashi, Konglah; Bareh, Jerryson (2013). "Tuberculous dactylitis (spina ventosa) with concomitant ipsilateral axillary scrofuloderma in an immunocompetent child: A rare presentation of skeletal tuberculosis". Advanced Biomedical Research. 2 (1): 29. doi: 10.4103/2277-9175.107993 . PMC   3748632 . PMID   23977657.
  11. Sunderamoorthy, D; Gupta, V; Bleetman, A (2001). "TB or not TB: an unusual sore finger". Emergency Medicine Journal. 18 (6): 490–1. doi:10.1136/emj.18.6.490. PMC   1725720 . PMID   11696511.
  12. Jensen, CM; Jensen, CH; Paerregaard, A (1991). "A diagnostic problem in tuberculous dactylitis". Journal of Hand Surgery (Edinburgh, Scotland). 16 (2): 202–3. doi:10.1016/0266-7681(91)90177-P. PMID   2061665. S2CID   10289363.
  13. Sequeira, W.; Co, H.; Block, J. A. (November 2000). "Osteoarticular tuberculosis: current diagnosis and treatment". American Journal of Therapeutics. 7 (6): 393–398. doi:10.1097/00045391-200007060-00009. ISSN   1075-2765. PMID   11304648.
  14. Nguyen Ngoc, Sang; Nguyen Thai, Ha; Vu Van, Quang; Vu Tung, Lam; Nguyen Ngoc, Rang; Nguyen Van, Hung (2021-07-05). "Late Discovering Spina Ventosa: A Case Report". International Medical Case Reports Journal. 14: 449–453. doi: 10.2147/IMCRJ.S318003 . ISSN   1179-142X. PMC   8273899 . PMID   34262359.